Status:

UNKNOWN

Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Conditions:

Cocaine-Related Disorders

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

To study of classical conditioning mechanisms associated with arousal, craving and cocaine use.

Detailed Description

This is a single-site, double-blind, placebo-controlled crossover study of classical conditioning mechanisms associated with arousal, craving and cocaine use.

Eligibility Criteria

Inclusion

  • Be English-speaking volunteers who are cocaine dependent
  • Be non-treatment seeking at the time of the study
  • Meet DSM-IV criteria for cocaine dependence
  • Have ECG showing normal sinus rhythm, normal conductivity, and non clinically significant arrhythmias
  • Females must provide a negative pregnancy test and agree to use birth control
  • Have baseline laboratory tests within normal limits

Exclusion

  • Please contact site for more information

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

End Date :

July 1 2005

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT00094315

Start Date

September 1 2004

End Date

July 1 2005

Last Update

January 11 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas Health Science Center

San Antonio, Texas, United States, 78284